Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive CommitteeSeptember 12, 2023
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.
Mr. Kaminsky, President of Pharmaceutical Solutions and Services at McKesson Corporation, has served on the Board and HDA Executive Committee since 2019. Mr. Hatcher, Chief Executive Officer of Morris & Dickson Co., L.L.C., has served on HDA’s governing bodies since 2021.
Additionally, Clint Syvinski, Co-CEO/Chief Operating Officer of Mutual Drug and current HDA Board member, was appointed to serve on the HDA Executive Committee. View a current listing of the Executive Committee members and Board of Directors.
“I look forward to continuing to work with Kirk and Jody over the next year as we tackle new and existing challenges facing the healthcare distribution industry,” said HDA President and CEO Chester “Chip” Davis, Jr. “Further, Clint’s experience and engagement will benefit HDA on the Executive Committee as we collectively work to ensure our industry has a strong voice in Washington and the states with policymakers and supply chain partners.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.